Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Connolly

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Clinical Cardiology|October 20, 2020
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA studyCarina Blomström-Lundqvist, Nassir Marrouche, Stuart Connolly, et al.
Clinical Cardiology|January 23, 2013
Effects of dronedarone started rapidly after amiodarone discontinuationLaura Immordino, Stuart Connolly, Harry Crijns, et al.
Atherosclerosis|April 6, 2023
The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trialMohammad Qadura, Muzammil H Syed, Sonia Anand, et al.
Journal of the American College of Cardiology|February 25, 2012
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) studyGreg Flaker, Michael Ezekowitz, Salim Yusuf, et al.
Circulation. Arrhythmia and Electrophysiology|February 8, 2013
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES studyGregory Y H Lip, Stuart Connolly, Salim Yusuf, et al.
Current Opinion in Cardiology|December 24, 2008
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial designAnthony S Tang, George A Wells, Malcolm Arnold, et al.
Pacing and Clinical Electrophysiology : PACE|September 22, 2009
Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillatorArnold Pinter, Iqwal Mangat, Victoria Korley, et al.
Thrombosis Research|February 25, 2016
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding eventsAmmar Majeed, Hun-Gyu Hwang, John W Eikelboom, et al.
JAMA|November 19, 2002
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysisCarl van Walraven, Robert G Hart, Daniel E Singer, et al.
American Heart Journal|April 21, 2009
Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatranMichael D Ezekowitz, Stuart Connolly, Amit Parekh, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Clinical Cardiology|October 20, 2020
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA studyCarina Blomström-Lundqvist, Nassir Marrouche, Stuart Connolly, et al.
Clinical Cardiology|January 23, 2013
Effects of dronedarone started rapidly after amiodarone discontinuationLaura Immordino, Stuart Connolly, Harry Crijns, et al.
Atherosclerosis|April 6, 2023
The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trialMohammad Qadura, Muzammil H Syed, Sonia Anand, et al.
Journal of the American College of Cardiology|February 25, 2012
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) studyGreg Flaker, Michael Ezekowitz, Salim Yusuf, et al.
Circulation. Arrhythmia and Electrophysiology|February 8, 2013
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES studyGregory Y H Lip, Stuart Connolly, Salim Yusuf, et al.
Current Opinion in Cardiology|December 24, 2008
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial designAnthony S Tang, George A Wells, Malcolm Arnold, et al.
Pacing and Clinical Electrophysiology : PACE|September 22, 2009
Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillatorArnold Pinter, Iqwal Mangat, Victoria Korley, et al.
Thrombosis Research|February 25, 2016
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding eventsAmmar Majeed, Hun-Gyu Hwang, John W Eikelboom, et al.
JAMA|November 19, 2002
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysisCarl van Walraven, Robert G Hart, Daniel E Singer, et al.
American Heart Journal|April 21, 2009
Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatranMichael D Ezekowitz, Stuart Connolly, Amit Parekh, et al.
Pageof 8